HealthCo Healthcare and Wellness REIT (ASX: HCW) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
HealthCo Healthcare and Wellness REIT Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$759.80 million
P/E Ratio
11.20
Dividend Yield
5.53%
Shares Outstanding
562.81 million
Earnings per share
0.122
Dividend per share
0.08
Year To Date Return
-17.31%
Earnings Yield
8.93%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
HealthCo Healthcare and Wellness REIT (ASX: HCW)
Latest News
Dividend Investing
Buy these ASX dividend shares for 5%+ yields
Dividend Investing
Morgans says these ASX dividend shares with 5%+ yields are buys
Dividend Investing
3 ASX dividend shares to buy right now for income
Dividend Investing
Analysts are tipping big yields from these ASX 300 dividend shares
Dividend Investing
Morgans says these ASX All Ords dividend shares are buys
Dividend Investing
Analysts say these ASX dividend stocks are buys for income investors
Dividend Investing
3 ASX dividend shares to buy in July according to analysts
Dividend Investing
Buy these ASX dividend stocks for passive income
Dividend Investing
Last chance to snag the next dividend on these 4 ASX All Ords shares
Dividend Investing
Buy these ASX dividend shares next week
How to invest
3 ASX dividend shares, 5% yields, and an early retirement plan!
Dividend Investing
Morgans rates these ASX dividend stocks as buys
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 29 Jun 2023 | $0.0200 | 0.00% | Final | 30 Aug 2023 |
| 01 May 2023 | $0.0188 | 0.00% | Interim | 23 Jun 2023 |
| 29 Dec 2022 | $0.0188 | 0.00% | Interim | 24 Feb 2023 |
| 29 Sep 2022 | $0.0188 | 0.00% | Interim | 25 Nov 2022 |
| 29 Jun 2022 | $0.0225 | 0.00% | Final | 22 Aug 2022 |
| 30 Mar 2022 | $0.0225 | 0.00% | Interim | 20 May 2022 |
| 30 Dec 2021 | $0.0300 | 0.00% | Interim | 25 Feb 2022 |
HCW ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About HealthCo Healthcare and Wellness REIT
HealthCo Healthcare and Wellness REIT are owning and managing a portfolio of commercial health and wellness real estate assets.
HCW Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 09 Aug 2023 | $1.35 | $-0.01 | -0.73% | 1,470,075 | $1.37 | $1.37 | $1.33 |
| 08 Aug 2023 | $1.37 | $-0.02 | -1.44% | 924,591 | $1.37 | $1.40 | $1.35 |
| 07 Aug 2023 | $1.39 | $0.02 | 1.47% | 513,075 | $1.37 | $1.39 | $1.37 |
| 04 Aug 2023 | $1.37 | $-0.01 | -0.73% | 301,384 | $1.37 | $1.37 | $1.35 |
| 03 Aug 2023 | $1.37 | $0.01 | 0.74% | 754,951 | $1.35 | $1.37 | $1.35 |
| 02 Aug 2023 | $1.36 | $-0.04 | -2.86% | 1,328,460 | $1.38 | $1.40 | $1.36 |
| 01 Aug 2023 | $1.40 | $-0.03 | -2.11% | 922,048 | $1.41 | $1.43 | $1.40 |
| 31 Jul 2023 | $1.43 | $0.02 | 1.42% | 779,407 | $1.43 | $1.44 | $1.42 |
| 28 Jul 2023 | $1.41 | $0.01 | 0.71% | 617,947 | $1.40 | $1.43 | $1.38 |
| 27 Jul 2023 | $1.40 | $0.03 | 2.20% | 696,266 | $1.37 | $1.41 | $1.37 |
| 26 Jul 2023 | $1.37 | $-0.01 | -0.72% | 543,827 | $1.38 | $1.41 | $1.36 |
| 25 Jul 2023 | $1.38 | $-0.03 | -2.14% | 647,881 | $1.42 | $1.42 | $1.36 |
| 24 Jul 2023 | $1.41 | $0.00 | 0.00% | 600,036 | $1.42 | $1.43 | $1.40 |
| 21 Jul 2023 | $1.41 | $-0.01 | -0.71% | 611,732 | $1.42 | $1.43 | $1.40 |
| 20 Jul 2023 | $1.42 | $0.05 | 3.68% | 921,205 | $1.36 | $1.42 | $1.35 |
| 19 Jul 2023 | $1.36 | $-0.01 | -0.73% | 979,085 | $1.38 | $1.40 | $1.36 |
| 18 Jul 2023 | $1.37 | $-0.01 | -0.72% | 1,071,683 | $1.38 | $1.40 | $1.37 |
| 17 Jul 2023 | $1.38 | $0.03 | 2.22% | 1,129,750 | $1.35 | $1.38 | $1.33 |
| 14 Jul 2023 | $1.35 | $0.00 | 0.00% | 969,933 | $1.35 | $1.36 | $1.33 |
| 13 Jul 2023 | $1.35 | $0.01 | 0.75% | 844,342 | $1.34 | $1.36 | $1.32 |
| 12 Jul 2023 | $1.34 | $0.01 | 0.75% | 584,859 | $1.34 | $1.35 | $1.33 |
| 11 Jul 2023 | $1.34 | $-0.07 | -5.00% | 905,280 | $1.34 | $1.35 | $1.30 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 28 Apr 2023 | Stephanie Lai | Issued | 5 | $6,845 |
Rights issue.
|
| 28 Apr 2023 | Stephanie Lai | Issued | 86 | $116,525 |
Rights issue.
|
| 28 Apr 2023 | David Di Pilla | Issued | 17 | $23,707,372 |
Rights issue.
|
| 28 Apr 2023 | Kelly O'Dwyer | Issued | 13 | $17,761 |
Rights issue.
|
| 28 Apr 2023 | Kelly O'Dwyer | Issued | 14 | $19,327 |
Rights issue.
|
| 28 Apr 2023 | Joseph Carrozzi | Issued | 112 | $152,011 |
Rights issue.
|
| 28 Apr 2023 | Natalie Meyenn | Issued | 20 | $28,162 |
Rights issue.
|
| 18 Apr 2023 | David Di Pilla | Issued | 23 | $32,000,000 |
Rights issue.
|
| 18 Apr 2023 | Christopher Roberts | Issued | 347 | $468,942 |
Rights issue.
|
| 03 Mar 2023 | Christopher Roberts | Buy | 40 | $63,200 |
On-market trade.
|
| 01 Mar 2023 | Christopher Roberts | Buy | 80 | $129,536 |
On-market trade.
|
| 27 Feb 2023 | Christopher Roberts | Buy | 40 | $63,800 |
On-market trade.
|
| 30 Aug 2022 | Kelly O'Dwyer | Buy | 17 | $31,446 |
As advised by the company. Acquisition of units pursuant to
participation in the FY22 voluntary nonexecutive director unit acquisition |
| 30 Aug 2022 | Natalie Meyenn | Buy | 14 | $26,101 |
As advised by the company. Acquisition of units pursuant to
participation in the FY22 voluntary nonexecutive director unit acquisition arrangement |
| 29 Aug 2022 | Joseph Carrozzi | Buy | 13 | $24,468 |
As advised by the company. Acquisition of units pursuant to
participation in the FY22 voluntary nonexecutive director unit acquisition arrangement as summarised in HCW's Product Disclosure Statement dated 2 August 2021. |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr Christopher Graham Roberts | Non-Executive Director | Aug 2021 |
Dr Roberts has over 40 years of experience in the medical device industry serving a number of senior management positions. He was the former CEO of Cochlear from 2004 to 2015 and is presently a member of the Cochlear Foundation Board, TEDI London and non-executive director of Clarity Pharmaceuticals Limited and Atmo Biosciences Ltd.
|
| Ms Stephanie Mei-Nga Lai | Non-Executive Director | Aug 2021 |
Ms Lai has over 20 years of experience as a Chartered Accountant and is a former Merger & Acquisitions partner of Deloitte and KPMG. She has experience providing due diligence and advisory services, including forecast reviews to listed entities, sovereign wealth funds, wealth managers and private equity.
|
| Mr David Anthony Di Pilla | Non-Executive Director | Jul 2021 |
Mr Pilla is the founder, a director and the shareholder of the Aurrum Aged Care group. From 2014 to 2016, he was also a strategic advisor and director to operating subsidiaries of the Tenix Group of Companies. David has over 20 years of experience in investment banking. From 2004 to 2015, he was Managing Director and Senior Adviser at UBS Australia.
|
| Hon Kelly Megan O'Dwyer | Non-Executive Director | Aug 2021 |
Ms O'Dwyer served in the Australian Parliament as a Senior Cabinet Minister holding a number of economic portfolios including Minister for Jobs and Industrial Relations; Minister for Revenue and Financial Services; Minister for Small Business; and Assistant Treasurer. She also served on the Cabinet's Budget Committee (the Expenditure Review Committee) and held the portfolios of Minister for Women; as well as Minister Assisting the Prime Minister with the Public Service.
|
| Mr Joseph Carrozzi | Non-Executive ChairmanNon-Executive Director | Aug 2021 |
Mr Carrozzi has over 25 years of experience as Partner in the Big 4 professional services firms, commencing with Tax and Legal leader at Andersens, Regional Managing Partner at EY and later joining PwC in 2005 as National Managing Partner, Markets and Sydney office. He also Chairs the Centenary Institute for Medical Research, the Sydney Harbour Federation Trust and Angus Knight Limited.
|
| Ms Natalie Jane Meyenn | Non-Executive Director | Aug 2021 |
Ms Meyenn has over 25 years' experience in financial services and investing globally. She has previously held the roles of CIO and Chair of the Investment Committee for MLC Private Equity. She has worked in investment banking (M&A, capital markets and public finance) in New York and Sydney for many years and spent time at the World Bank working in Asia, Africa and the Pacific Islands on microfinance, project finance and climate change impact mitigation strategies.
|
| Mr Andrew Selim | Company SecretaryGeneral Counsel |
-
|
|
| Andrew Selim | Company SecretaryGeneral Counsel |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Home Consortium Limited | 68,121,536 | 20.94% |
| HSBC Custody Nominees (Australia) Limited | 45,243,410 | 13.90% |
| National Nominees Limited | 23,670,172 | 7.27% |
| JP Morgan Nominees Australia Pty Limited | 15,780,225 | 4.85% |
| Citicorp Nominees Pty Limited | 14,219,417 | 4.37% |
| BNP Paribas Noms Pty Ltd | 11,177,715 | 3.44% |
| UBS Nominees Pty Ltd | 8,257,387 | 2.54% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 6,318,176 | 1.94% |
| Netwealth Investments Limited (Wrap Services A/C) | 4,986,406 | 1.53% |
| BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd | 2,490,602 | 0.77% |
| Seymour Group Pty Ltd | 1,650,000 | 0.51% |
| Bridgebox Pty Limited | 1,500,000 | 0.46% |
| Netwealth Investments Limited (Super Services A/C) | 1,421,502 | 0.44% |
| Sword Equity Investments Pty Ltd | 1,375,000 | 0.42% |
| Goat Properties Pty Ltd | 1,250,000 | 0.38% |
| BNP Paribas Nominees Pty Ltd (Pitcher Partners DRP) | 1,150,909 | 0.35% |
| Premium Capital (Aust) Pty Ltd | 1,082,000 | 0.33% |
| Custodial Services Limited (Beneficiaries Holding A/C) | 605,110 | 0.19% |
| Vaste Developments Pty Limited | 600,000 | 0.18% |
| Johnos Holdings Pty Ltd | 500,000 | 0.15% |